Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy.
- Published In:
- Drug design, development and therapy, 17, 155-166 (2023)
- Database ID:
- RPEP-07407
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07407APA
Soriano, Vicente; Moreno-Torres, Victor; Treviño, Ana; Corral, Octavio; de Mendoza, Carmen. (2023). Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy.. Drug design, development and therapy, 17, 155-166. https://doi.org/10.2147/DDDT.S379964
MLA
Soriano, Vicente, et al. "Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy.." Drug design, 2023. https://doi.org/10.2147/DDDT.S379964
RethinkPeptides
RethinkPeptides Research Database. "Bulevirtide in the Treatment of Hepatitis Delta: Drug Discov..." RPEP-07407. Retrieved from https://rethinkpeptides.com/research/soriano-2023-bulevirtide-in-the-treatment
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.